Silverback Therapeutics
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Silverback Therapeutics's balance sheet done over the years? Its assets were worth $281,435,000 last year, which is less than in the previous period. 3% of Silverback Therapeuticsโ€™s total assets is currently financed by debt. Its liabilities reached the amount of $8,549,000, which means an decrease by -56% compared compared to last year.

Debt to Assets

Silverback Therapeutics, Inc. (NASDAQ:SBTX): Debt to assets
2018 27547000 62.52M 226.97%
2019 15647000 74.42M 475.64%
2020 394804000 11.92M 3.02%
2021 333467000 19.65M 5.89%
2022 281435000 8.54M 3.04%

SBTX Balance Sheet (2018 โ€“ 2022)

2022 2021 2020 2019 2018
Assets
Current assets:
Cash and cash equivalents
210.51M254.04M386.56M9.97M20.16M
Short term investments
63.86M0000
Net receivables
00000
Inventory
00000
Other current assets
3.31M7.44M4.08M552K618K
Total current assets
277.7M261.49M390.65M10.52M20.77M
Non-current assets:
Property, Plant and Equipment
774K6.94M3.79M4.56M6.01M
Goodwill
00000
Intangible assets
00000
Long term investments
064.78M000
Other non-current assets
2.96M250K350K550K750K
Total non-current assets
3.73M71.97M4.14M5.11M6.76M
Total assets
281.43M333.46M394.80M15.64M27.54M
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
00000
Short term debt
230K1.08M844K11.51M2.84M
Total current liabilities
5.44M14.89M9.60M17.92M5.14M
Non-current liabilities:
Long term debt
251K4.76M2.32M00
Deferred tax
00000
Other non-current liabilities
2.85M0056.49M57.38M
Total non-current liabilities
3.10M4.76M2.32M56.49M57.38M
Total liabilities
8.54M19.65M11.92M74.42M62.52M
Data sourceData sourceData source